Vol. 277, Issue 3, H1081-H1088, September 1999
Inactivation gating determines nicotine blockade of human HERG
channels
Hui-Zhen
Wang1,
Hong
Shi1,
Shu-Jie
Liao3, and
Zhiguo
Wang1,2
1 Research Center, Montreal
Heart Institute, Montreal H1T 1C8;
2 Department of Medicine,
University of Montreal, Montreal, Quebec, Canada H3C 3J7; and
3 Department of Pharmacology,
Zhelimumeng Medical School, Tongliao, Inner Mongolia 028000, China
 |
ABSTRACT |
We have previously found that nicotine blocked
multiple K+ currents, including
the rapid component of delayed rectifier
K+ currents
(IKr), by
interacting directly with the channels. To shed some light on the
mechanisms of interaction between nicotine and channels, we performed
detailed analysis on the human
ether-à-go-go-related gene
(HERG) channels, which are believed to be equivalent to the native
IKr when
expressed in Xenopus oocytes. Nicotine
suppressed the HERG channels in a concentration-dependent manner with
greater potency with voltage protocols, which favor channel
inactivation. Nicotine caused dramatic shifts of the voltage-dependent
inactivation curve to more negative potentials and accelerated the
inactivation process. Conversely, maneuvers that weakened the channel
inactivation gating considerably relieved the blockade. Elevating the
extracellular K+ concentration
from 5 to 20 mM increased the nicotine concentration (by ~100-fold)
needed to achieve the same degree of inhibition. Moreover,
nicotine lost its ability to block the HERG channels when a single
mutation was introduced to a residue located after transmembrane domain
6 (S631A) to remove the rapid channel inactivation. Our data suggest
that the inactivation gating determines nicotine blockade of the HERG channels.
Xenopus oocyte; voltage-clamp
techniques
 |
INTRODUCTION |
NICOTINE, a cyclic alkaloid, is the main constituent of
tobacco smoke responsible for the elevated risk of the cardiovascular disease and sudden coronary death associated with smoking (13). It is
thought that nicotine causes its acute adverse effects by provoking
cardiac arrhythmias (3, 8, 9, 15, 24, 31). The mechanisms by which
nicotine favors arrhythmias have been attributed to its ability to
enhance catecholamine release as a result of stimulation of nicotinic
acetylcholine receptors (nAChRs) (2). However, we have recently found
that nicotine can also block a number of
K+ currents by interacting
directly with these channels without the involvement of nAChRs and
catecholamine release (26). The currents sensitive to nicotine include
inward rectifier K+ current
(IK1),
transient outward K+ current
(Ito), and the
rapid component of the classic delayed rectifier
K+ currents
(IKr) in dog
ventricular myocytes (26). Blockade of K+ currents may provide an
explanation, complementary to the "catecholamine release" theory
(2), for previously observed membrane depolarization and action
potential duration (APD) prolongation caused by nicotine (7, 11, 16).
It is of interest and importance to understand in depth the mechanisms
by which nicotine interacts with cardiac
K+ channels to understand the
pathophysiological implications of nicotine's action. Yet, a potential
problem of studying endogenous currents is the difficulty of accurately
dissecting each of the multiple currents from others that coexist in a
single cell. Studies using cloned channels equivalent to the native
channels would help us better understand the problem and the
characteristics of drug-channel interactions. In particular, the
ability of nicotine to block
IKr may account
to some extent for its ability to lengthen APD and to alter the
propensity of arrhythmias. We therefore assessed in the present study
the effects of nicotine on the human HERG channels that generate
currents, when expressed in Xenopus
oocytes, equivalent to the endogenous current
IKr (20).
 |
METHODS |
Functional expression in Xenopus laevis
oocytes.
Procedures for in vitro transcription and oocyte injection have been
previously described in detail (30). HERG (a kind gift from Dr. Mark
Keating) was subcloned into pSP64 vector. The S631A mutant of HERG is a
kind gift from Dr. Terence E. Hébert. cRNAs were prepared with
the mMESSAGE mMACHINE kit (Ambion) using SP6 RNA polymerase according
to manufacturer's protocols. cRNAs were dissolved in diethyl
pyrocarbonate-treated sterile water, stored at
80°C, and
diluted immediately prior to injection. Stage V-VI Xenopus oocytes were injected with 46 nl of cRNA.
Two-electrode voltage-clamp recording.
Approximately 48 h after cRNA injection, two-electrode voltage clamp
was performed on individual oocytes as previously described (30).
Electrodes filled with 3 M KCl containing 10 mM HEPES had a resistance
of ~0.6-2 M
when measured in the bath solution containing the
following (in mM): 100 NaCl, 5 KCl, 0.3 CaCl2, 2 MgCl2, and 10 HEPES (pH 7.4). The
electrodes were connected to a GeneClamp-500 amplifier (Axon
Instrument, Burlingame, CA). The pCLAMP suite of programs was employed
for data acquisition and analysis. Records were digitized at 5 kHz and
filtered at 2 kHz. Experiments were conducted at room temperature
(22-23°C).
Data analysis.
Group data are means ± SE. Statistical comparisons among groups
were performed by ANOVA. If significant effects were indicated by
ANOVA, a t-test with Bonferroni
correction or a Dunnett's test was used to evaluate the significance
of differences between individual means. Otherwise, baseline and drug
data were compared by Student's t-test. A two-tailed
P < 0.05 was taken to indicate a
statistically significant difference. A nonlinear least-square
curve-fitting program (CLAMPFIT in pCLAMP 6.0 or Graphpad Prism) was
used to perform curve-fitting procedures.
 |
RESULTS |
Expression of HERG resulted in the induction of a
K+ conductance with characteristic
activation and rectification properties of the endogenous
IKr. Because of
the rapid C-type inactivation of the HERG channels compared with their
activation, outward currents at potentials positive to 0 mV became
smaller (21, 23, 27). The inactivation is rapidly weakened on
hyperpolarization to negative potentials, as indicated by the rising
phase of the tail currents (Fig.
1). Nicotine applied to the
superfusion solution produced concentration-dependent suppression of
the HERG channels, as illustrated in Fig. 1.

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Nicotine (Nic) block of human
ether-à-go-go-related gene
(HERG) channels expressed in Xenopus
oocytes. Currents were elicited by voltage protocols
(inset). Pulse length was 2 s and
pulses were delivered every 10 s. Shown are analog data obtained under
control conditions and in presence of various concentrations of Nic.
|
|
Voltage dependence.
The voltage dependence of HERG blockade by nicotine was assessed with
three different voltage protocols, i.e., the standard current-voltage
(I-V)
protocols, the fully activated
I-V
protocols, and the instantaneous
I-V
protocols. With the standard
I-V
protocols, activating currents were elicited by 2-s depolarizing pulses
ranging from
60 to +50 mV and tail currents by 1-s repolarizing
pulses to
50 mV. The voltage steps were delivered from a holding
potential (HP) of
70 mV at an interpulse interval of 10 s. The
standard I-V
relationship demonstrated strong inward rectification from potentials
positive to
10 mV. Nicotine diminished the currents at various
concentrations from 1 to 1,000 µM (Fig.
2A,
top). The degree of blockade
appeared enhanced with stronger depolarization and stronger apparent
inward rectification or rapid inactivation from
30 and +30 mV
(Fig. 2A,
bottom). To determine the fully activated
I-V
relationships, a 1-s prepulse to +40 mV was applied before each of the
repolarizing pulses to the test potentials ranging from
140 mV
to +20 mV. Note that the prepulse potential to +40 mV was positive
enough to induce full conductance of the channels but also rendered a
large amount of channels into the inactivated state (see Fig. 4). Thus
the fully activated
I-V
curve also demonstrated striking inward rectification with a negative slope from potentials more positive than
20 mV. Nicotine
produced a block of the currents at all test potentials with more
pronounced inhibition at potentials between
60 to 0 mV (Fig.
2B). Similar to the standard
I-V
data, the inhibitory effects of nicotine were more pronounced as the
channel rectification (inactivation) manifested at positive potentials.
The reduced potency at potentials positive to +30 mV with the standard
I-V
protocols (Fig. 2A,
bottom) could be explained by the
relatively slow association rate of nicotine to the HERG channels
compared with the rate of endogenous channel inactivation at such
positive potentials. In other words, the HERG channel inactivation
occurred largely before nicotine could bind to the channels and produce
the inhibitory effects. If it is true that nicotine blockade depends on
channel inactivation, then removal of rectification should eliminate
the correlation between the blockade and the voltage. Hence, the
instantaneous I-V
protocols were used to test this possibility. The channels were first
inactivated by clamping the membrane at +40 mV for 1 s followed by a
prepulse to
100 mV for 20 ms. This prepulse was long enough for
rapid recovery of the HERG channels from inactivation but was short
enough to prevent significant channel deactivation. After the recovery
prepulse, a family of test pulses were delivered to potentials ranging
from
140 to +20 mV. The currents recorded at the test pulses
were fitted by the single exponential function with extrapolation to
the initial point of the test pulse, and the amplitude was plotted
against test potentials (TPs) to construct the instantaneous
I-V
curves. The
I-V
relationships from such protocols were linear (Fig.
2C,
top) because minimal inactivation occurred during the prepulse. This protocol resulted in significantly less HERG-channel blockade (Fig. 2C,
bottom) when compared with the
standard and the fully activated
I-V
protocols.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 2.
Voltage-dependent effects of Nic on HERG channels expressed in
Xenopus oocytes.
Top: current-voltage
(I-V)
relationships assessed by 3 different
I-V
protocols, including standard
I-V
protocols (A), fully activated
I-V
protocols (B), and instantaneous
I-V
protocols (C).
Bottom: percent blockade of HERG
channels as a function of test potentials (TP) calculated from
corresponding voltage protocols.
|
|
The percent reduction at a given TP was smaller with instantaneous
I-V
protocols compared with the other two protocols. For example, at 0 mV,
the reduction of HERG currents by 5 µM nicotine was 23.1 ± 6.0%
with the standard
I-V
protocols, 43.7 ± 6.7% with the fully activated
I-V
protocols, and only 12.6 ± 4.5% with the instantaneous
I-V
protocols (Fig.
3B). The
inhibitory potency of nicotine was evaluated with the three different
voltage protocols, as illustrated in Fig.
3C. The dose-response curves were
constructed by plotting the percent block of the step currents at a TP
of 0 mV as a function of drug concentrations. The
IC50 values calculated from the
Hill equation were 16.8 ± 2.2 µM (Hill coefficient = 0.74) for
the standard
I-V
protocols and 1.8 ± 0.3 µM (Hill coefficient = 0.51)
for the fully activated
I-V
protocols. The values for the instantaneous
I-V
protocols could not be calculated because the concentrations of
nicotine used were not high enough to reach maximal effects.
Apparently, nicotine is ~10 times and at least 100 times more potent
with the fully activated
I-V
protocols than with the standard and the instantaneous
I-V
protocols, respectively. It appears that the conditioning pulses that
render the channels inactivated can facilitate the drug binding and
blockade.

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 3.
Potency comparison of HERG-channel blockade by Nic with different
voltage protocols in Xenopus oocytes.
A: typical examples of currents
elicited by 3 different voltage protocols as described in Fig. 2
[standard
I-V
protocols (left), fully activated
I-V
protocols (middle), instantaneous
I-V
protocols (right)]. Only currents
recorded at 0 mV are shown. B: percent
blockade of HERG channels by Nic (5 µM) determined at a TP of 0 mV.
* P < 0.05 and
** P < 0.01 vs. control.
C: dose-response curves of
HERG-channel blockade by Nic determined with 3 different voltage
protocols. Symbols are experimental data averaged from 6 cells for
varying concentrations; lines represent best fits to the Hill equation:
B(%) = 100/[1 + (IC50/D)nH].
B(%), percent change of HERG channels at a drug concentration D;
IC50, concentration of Nic that
produces 50% inhibition of the current; nH,
Hill coefficient.
|
|
Effects on the activation and inactivation properties.
The fact that nicotine blocks the HERG channel more strongly at
potentials with apparent rectification (or inactivation, the standard
I-V
and the fully activated
I-V
vs. the instant
I-V) and particularly with inactivating prepulses (the fully activated I-V
vs. the standard
I-V)
suggests that nicotine preferentially blocks the HERG channels when
they are in the inactivated state. If this is true, then it is expected
that nicotine should be able to alter the inactivation parameters but
leave the activation gating unchanged. Therefore, we performed analysis
on the data regarding the voltage-dependent activation and inactivation
gating properties and the drug effects. The activation curves were
constructed by normalizing the tail currents recorded with the standard
I-V protocols. The normalized data (or conductance) were plotted against the prepulse potentials and fitted to the Boltzmann distribution. Nicotine at concentrations lower than 1,000 µM did not alter the activation parameters (Fig. 4): the
half-maximum activation voltages (activation
V1/2 values) were
36.6 ± 4.3 mV under control conditions and
30.6 ± 5.1 mV with 100 µM nicotine (P > 0.05, n = 5). Nicotine at
1,000 µM produced slight but statistically significant changes in
V1/2 values. In
contrast, the inactivation characteristics were markedly affected by
nicotine, as illustrated in Fig. 4, C
and D. Nicotine caused apparent shifts
of the inactivation curves to the negative direction in a
concentration-dependent fashion. The half-maximal inactivation voltage
(inactivation
V1/2 values) was
changed from
49.9 ± 4.4 mV under control conditions to
55.4 ± 3.6,
61.8 ± 6.5, and
88.6 ± 8.7 mV with the drug concentrations of 1 (P < 0.05, n = 5), 5 (P < 0.01, n = 6), and 1,000 µM
(P < 0.01, n = 6), respectively. The
slope factor was not significantly altered (
26.7 ± 3.4 mV
for control vs.
23.9 ± 2.9 mV for nicotine at 1 mM,
P > 0.05, n = 6). The blockade of the currents
elicited at the TP of 0 mV was more prominent with less negative
prepulse potentials. For example, at a holding potential of
80
mV, nicotine produced a 22.4 ± 9.0, 34.1 ± 7.5, and 50.9 ± 11.1% reduction of the activating current amplitude at 1, 5, and 10 µM, respectively. In comparison, the respective percent block
increased to 36.9 ± 7.5, 50.2 ± 6.0, and 71.5 ± 3.5 at a
holding potential of
20 mV. Note that even at
140 mV, nicotine still caused certain degrees of blockade (15.4 ± 7.0, 23.5 ± 7.8, and 37.9 ± 14.9% by 1, 5, and 10 µM nicotine,
respectively). The results indicated that the inactivation of the HERG
channels facilitated nicotine binding to the channels and that the
channel blockade was not merely a consequence of a steady-state
inactivation shift.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of Nic on voltage-dependent activation and inactivation
properties of HERG channels in Xenopus
oocytes. A: analog data showing tail
currents elicited on repolarization to 50 mV, after 2-s
prepulses from 60 to +20 mV. B:
average data showing effects of Nic on conductance curve of HERG
channels. Tail currents (A) were
normalized to maximum value obtained with a prepulse to +20 mV, and
conductance (normalized tail currents) was plotted against prepulse
voltage to construct activation conductance curve. Symbols are
experimental data (n = 6), and lines
represent best fits to Boltzmann distribution:
I/Imax = 1/{1 + exp[(V1/2 V)/k]}.
I, current amplitude at a prepulse
potential V;
Imax, maximal
tail current amplitude after a prepulse to +20 mV;
V1/2, voltage for
half-maximal activation; k, slope
factor. C:
examples of currents elicited with
protocols shown (inset) to evaluate
inactivation properties of HERG channels before and after Nic.
D: negative shift of inactivation
curves by Nic. To construct inactivation curves, voltage protocols
(inset,
C) were employed: a 2-s depolarizing
pulse to inactivate HERG channels followed by varying repolarizing
pulses to potentials between 140 and +20 mV for a short period
of 20 ms, followed by a test pulse to +20 mV. Current amplitude at TP
was normalized and plotted against prepulse potentials. Symbols are
experimental data and curves represent best fits to Boltzmann
distribution.
|
|
Effects on kinetics.
Once activated, the HERG channels undergo complex process from closed
states to open/inactivation, inactivation, deactivation, and finally to
closed states again. Open channel blockers often cause apparent
acceleration of activation time course and/or apparent deceleration of
deactivation time course because of reopening of the channels caused by
drug unbinding. The activation time course was described by the single
exponential function on the currents evoked at the TP of
20 mV
from a HP of
70 mV. Nicotine did not significantly alter the
activation time course, as indicated by the similar time constants
before (403 ± 30 ms) and after 100 µM nicotine (384 ± 34 ms,
P > 0.05, n = 7). The deactivation time constants were obtained by fitting, to the double exponential function,
the tail currents elicited by a hyperpolarizing pulse to
120 mV
after a 2-s prepulse at +40 mV. The descending phase represents
recovery from inactivation, and the following rising phase represents
the deactivation time course. The deactivation time constants were 75.6 ± 8.9 ms under control conditions and 78.4 ± 11.6 ms in the
presence of 100 µM nicotine (P > 0.05, n = 6). Similarly, nicotine
failed to change the recovery time course (2.7 ± 0.4 ms for control
and 2.8 ± 0.4 ms for nicotine at 100 µM,
P > 0.005, n = 6), too.
In sharp contrast, nicotine markedly accelerated the inactivation time
course of the HERG channels. The inactivation process was analyzed by
fitting the currents elicited with the voltage protocols described in
the inset of Fig.
5 to the single exponential function. A
20-ms hyperpolarizing pulse to
100 mV was sufficient for
recovery from inactivation but too short to cause significant deactivation. The following depolarization-induced initial outward current reflects the open state of the HERG channels, which then again
inactivate rapidly. Therefore, the decaying tail currents represent the
HERG-channel inactivation but not deactivation. Examples are shown in
Fig. 5A, and the averaged data on the
concentration-dependent decreases in the inactivation time constant
induced by nicotine are illustrated in Fig.
5B.

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 5.
Effects of Nic on inactivation kinetics of HERG channels in
Xenopus oocytes.
A: currents obtained with voltage
protocols shown (inset). Each trace
was normalized to its maximum value, and normalized currents for
control and Nic are superimposed for better comparison.
B: averaged inactivation time
constants ( ) calculated from the single exponential fits to current
traces recorded under control conditions and in presence of various
concentrations of Nic, as indicated.
|
|
Effects of high external K+ concentration.
The data discussed above point to one possibility:
nicotine blocks the HERG channels by preferentially interacting with
the inactivated channels. It is known that the unusually rapid
inactivation of HERG channels is caused by C-type inactivation that is
highly sensitive to external K+
concentrations
([K+]o)
(28). Elevated
[K+]o
markedly slowed the kinetics and amplitude of the HERG-channel inactivation. Weakening of the HERG inactivation gating should relieve
nicotine blockade. This was indeed confirmed by the following experiments. The HERG currents were recorded with 20 mM
[K+]o,
and the drug effects were evaluated with the three different I-V
voltage protocols as already described above. The extent of channel
blockade by nicotine also became smaller with higher
[K+]o:
10 µM nicotine failed to affect the HERG channels regardless of
I-V
protocols used. In addition, to reach statistically significant blockade, nicotine concentration has to be raised to 100 µM
(decreased by 35.9 ± 3% at 0 mV with the standard
I-V
protocols). Comparison of the percent inhibition of the HERG channels
with different [K+]o
is presented in Fig. 6.

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of Nic on HERG channels under elevated external
K+ concentration
([K+]o).
Currents were recorded with
[K+]o
of 20 mM. A: analog data obtained with
standard
I-V
protocols as described in Fig. 1. B:
percent blockade of HERG channels with
[K+]o
of 20 mM at 0 mV with 3 different protocols, compared with that with
[K+]o
of 5 mM. * P < 0.05 and
** P < 0.01 vs. control.
|
|
Effects on inactivation-deficient mutant (S631A).
To further investigate the possibility of inactivation block of the
HERG channels by nicotine, we evaluated the effects of this compound on
S631A mutant of the HERG channel, in which the rapid C-type
inactivation gating is removed. The expression of S631A in oocytes gave
rise to delayed-rectifier-like currents with rapid activation and only
slight inactivation during the 2-s pulse. The inward rectification seen
with the wild-type HERG channels was absent in the mutant (Fig.
7, A and
B). For comparison, three different
I-V
protocols were used to assess the drug effects. The results are
illustrated in Fig. 7. The potency of the drug effects was apparently
diminished in the mutant. Nicotine at 5 µM, which suppressed the
wild-type HERG channels by 12 to ~42% depending on different voltage
protocols, did not at all affect the currents expressed by the mutated
HERG channels. Elevation of the drug concentration by 2,000-fold to 10 mM still failed to exhibit any effects on the channels.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of Nic on inactivation-deficient mutant of HERG channels
(S631A). A: raw data from a
representative oocyte. Currents were elicited with standard
I-V
protocols. B: superimposed
I-V
curves in absence and presence of 10 mM Nic.
C: percent blockade of S631A mutant by
10 mM Nic with 3 different
I-V
protocols as described in Fig. 2.
|
|
 |
DISCUSSION |
In the present study, we performed detailed analysis of nicotine-HERG
channel interactions, in terms of the voltage dependence and
concentration dependence as well as time dependence. We demonstrated that nicotine blocked the human HERG channels expressed in
Xenopus oocytes, consistent with its
ability to block
IKr (the
physiological counterpart of the HERG channels) in our previous study
(26). This study represents the first detailed characterization of
direct interactions between nicotine and
K+ channels. A novel finding in
this study is that the inactivation gating of the human HERG channels
determines the potency of nicotine blockade.
The detailed analyses of our data revealed that blockade of the HERG
channels by nicotine is mainly caused by the binding of nicotine to the
inactivated channels. Our data provided several lines of evidence in
support of this notion. First, nicotine produced more pronounced
inhibition of the HERG channels with the voltage protocols that
rendered the channels more in the inactivated state. For example,
nicotine has higher potency when the test pulses are preceded by a
conditioning pulse (2 s, to +40 mV), which favors channel inactivation.
In addition, depolarized membrane potentials or less negative holding
potentials facilitate nicotine binding to the HERG channels and promote
the inhibitory effects. The second line of evidence is that nicotine
caused marked negative shifts of the inactivation curves and
alterations of inactivation parameters (the
V1/2 values),
although it left the voltage-dependent activation properties unchanged.
The inactivation time course was also substantially accelerated by
nicotine, whereas the activation time constant was not altered. Third,
maneuvers that weakened or removed the channel inactivation such as the
use of the instantaneous
I-V protocols and elevation of
[K+]o
all substantially relieved the channels from blocking. Finally, more
convincing data were obtained from the experiments demonstrating a
failure of nicotine (up to 10 mM) to affect the inactivation-deficient mutant (S631A) of the HERG channels. The results from the mutant seem
to suggest that the channel inactivation is absolutely required for
nicotine block of the HERG channels. A similar mode of drug-HERG interactions has also been documented in several studies using antiarrhythmic (6, 22) and nonantiarrhythmic agents (17, 18, 25). For
example, Suessbrich et al. (25) reported blockade of HERG by
haloperidol (an antipsychotic drug) with similar potency to nicotine.
The mechanism of haloperidol block involves binding to inactivated
channels as inactivation enhanced and removal of inactivation weakened
the inhibition. A study utilizing inactivation-deficient mutant (S620T)
by Ficker et al. (10) also elegantly demonstrated that the inhibitory
potency of dofetilide on HERG was considerably reduced in the absence
of channel inactivation gating, as in our study with S631A mutant. The
authors concluded that a C-type inactivation process is crucial for
high-affinity binding of dofetilide (10). Similarly, a study by
Herzberg et al. (12) also clearly demonstrated that the blockade of
HERG by E-4031 was largely diminished with the mutations disabling the
rapid HERG channel inactivation.
Decrease in IKr
has been implicated in a variety of diseased states of the heart,
including myocardial infarction and ischemia, cardiac
hypertrophy, and heart failure, etc. (4, 5, 14, 29, 30,
32). This decrease is often accompanied by generation of
arrhythmias, such as ectopic beats, early afterdepolarization, and
triggered activity (1, 32). Reduction of
IKr could be antiarrhythmic (e.g., the reentrant types of arrhythmias) or
proarrhythmic (e.g., early afterdepolarization, long Q-T syndrome).
Nicotine has been associated with the elevated risk of sudden coronary death (13) by provoking arrhythmias (3, 8, 9, 15, 24, 31) through
interfering with the electrical activity of the heart. The averaged
blood levels of nicotine are about 200 nM in smokers (2) and the peak
concentration can reach up to 440 nM 2 h after one cigarette and could
be much higher in heavy smokers (19). Nicotine (0.1 to 1 µM) used in
our experiments is therefore comparable with the blood levels in the
smokers. Nicotine (0.1 µM) blocks the HERG channels by about 11% at
the TP of 0 mV in the present study and blocked 17%
IKr in our
previous studies (26). The percent blockade by 0.1 µM nicotine (11%) is small but could be physiologically significant considering the high
impedance of the plateau phase repolarization. It should be noted that
the efficacy of nicotine might have been underestimated in our study
because the cytoplasm of oocytes is packed with lipophilic yolk
granules that can absorb the drugs and also because the experiments were conducted at room temperature (22-23°C), which can often decrease drug-target interactions. It is not unreasonable to speculate that HERG (IKr)
blockade contributes to the ability of nicotine to alter the cardiac
electrical activity. On the basis of the unique property of
inactivation-dependent HERG-channel blockade by nicotine, blockade of
IKr would be more
pronounced during cardiac infarction or myocardial ischemia,
because membrane depolarization occurs under these situations. However,
whether the blockade of HERG
(IKr) by
nicotine is associated with its adverse effects on cardiovascular
diseases is still unclear from our data. This notion absolutely awaits
further studies with appropriate animal models, and the physiological
relevance cannot be drawn on the basis of the present study alone.
Although our data indeed provide some insights into the mechanisms of
the interactions or how nicotine blocked the channels, definite
conclusions in this regard cannot be drawn from our data. Studies using
more site-directed mutagenesis are required to have better
understanding of nicotine-channel interactions and the potential
binding sites of nicotine in the HERG channels.
In conclusion, nicotine blocks the HERG channels expressed in
Xenopus oocyte in a
concentration-dependent manner, which is in agreement with our
observations on the inhibition of
IKr in canine
ventricular cells. The effects of nicotine appear to be dependent on
the inactivation gating of the HERG channels, with the blockade
enhanced with predominant inactivation and relieved in the absence of
inactivation. Our study represents the first detailed investigation of
nicotine's direct interaction with the cloned channels, which reveals
a novel aspect of nicotine's pharmacology.
 |
ACKNOWLEDGEMENTS |
We thank XiaoFan Yang for excellent technical assistance and Drs.
Mark Keating and Terry Hébert for providing the clones used in
this study.
 |
FOOTNOTES |
This work was supported in part by the Smokeless Tobacco Research
Council Grant 0739-01, the Medical Research Council of Canada, the
Heart and Stroke Foundation of Quebec, an Establishment Grant for young
investigators from the Fonds de Recherche en Sante de Quebec awarded to
Z. Wang, and the Fonds de la Recherche de l'Institut de Cardiologie de
Montreal. Z. Wang is a research scholar of the Heart and Stroke
Foundation of Canada.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: Z. Wang,
Research Center, Montreal Heart Institute, 5000 Belanger East,
Montreal, PQ, Canada H1T 1C8 (E-mail:
wangz{at}icm.umontreal.ca).
Received 22 January 1999; accepted in final form 27 April 1999.
 |
REFERENCES |
1.
Beaumont, J.,
D. C. Michaels,
M. Delmar,
J. Davidenko,
and
J. Jalife.
A model study of changes in excitability of ventricular muscle cells: inhibition, facilitation, and hysteresis.
Am. J. Physiol.
268 (Heart Circ. Physiol. 37):
H1181-H1194,
1995[Abstract/Free Full Text].
2.
Benowitz, N. L.
Pharmacological aspects of cigarette smoking and nicotine addiction.
N. Engl. J. Med.
319:
1318-1330,
1988[Medline].
3.
Benowitz, N. L.,
and
S. C. Gourlay.
Cardiovascular toxicity of nicotine: implications for nicotine replacement therapy.
J. Am. Coll. Cardiol.
29:
1422-1431,
1997[Abstract].
4.
Beuckelmann, D. J.,
M. Näbauer,
and
E. Erdmann.
Alterations of K+ currents in isolated human ventricular myocytes from patients with terminal failure.
Circ. Res.
73:
379-385,
1993[Abstract/Free Full Text].
5.
Boyden, P. A.,
and
C. D. Jeck.
Ion channel function in disease.
Cardiovasc. Res.
29:
312-318,
1995[Medline].
6.
Busch, A. E.,
B. Eigenberger,
N. K. Jurkiewicz,
J. J. Salata,
A. Pica,
H. Suessbrich,
and
F. Lang.
Blockade of HERG channels by the class III antiarrhythmic azimilide: mode of action.
Br. J. Pharmacol.
123:
23-30,
1998[Medline].
7.
Carryl, O. R.,
A. Gallardo-Carpentier,
and
R. G. Carpentier.
Effects of nicotine and ethanol on rat atrial membrane potentials.
Alcohol
9:
87-92,
1992[Medline].
8.
Chevalier, H. J.,
B. Bandilla,
W. Dontenwill,
and
J. Hanel.
Effect of high doses of nicotine in pig. I. Changes of the electrocardiogram.
Basic Res. Cardiol.
71:
68-75,
1976[Medline].
9.
Escobedo, L. G.,
and
M. M. Zack.
Comparison of sudden and nonsudden coronary deaths in the United States.
Circulation
93:
2033-2036,
1996[Abstract/Free Full Text].
10.
Ficker, E.,
W. Jarolimek,
J. Kiehn,
A. Baumann,
and
A. M. Brown.
Molecular determinants of dofetilide block of HERG K+ channels.
Circ. Res.
82:
386-395,
1998[Abstract/Free Full Text].
11.
Greenspan, K.,
R. E. Edmands,
S. B. Knoebel,
and
C. Fisch.
Some effects of nicotine on cardiac automaticity, conduction, and inotropy.
Arch. Intern. Med.
123:
707-712,
1969[Abstract/Free Full Text].
12.
Herzberg, I. M.,
C. M. Trudeau,
and
G. A. Robertson.
Transfer of rapid inactivation and sensitivity to the class III antiarrhythmic drug E-4031 from HERG to M-eag channels.
J. Physiol. (Lond.)
511:
3-14,
1998[Abstract/Free Full Text].
13.
Keeley, E. C.,
M. J. Pirwitz,
C. Landau,
R. A. Lange,
L. D. Hillis,
E. H. Poerster,
K. Conrad,
and
J. E. Willard.
Intranasal nicotine spray does not augment the adverse effects of cigarette smoking on myocardial oxygen demand or coronary arterial dimensions.
Am. J. Med.
101:
357-363,
1996[Medline].
14.
Koumi, S.,
C. I. Backer,
and
C. E. Arentzen.
Characterization of inwardly rectifying K+ channel in human cardiac myocytes: Alterations in channel behavior in myocytes isolated from patients with idiopathic dilated cardiomyopathy.
Circulation
92:
164-174,
1995[Abstract/Free Full Text].
15.
Myerburg, R. J.,
K. M. Kessler,
and
A. Castellanos.
Sudden cardiac death: epidemiology, transient risk, and intervention assessment.
Ann. Intern. Med.
119:
1187-1197,
1992.
16.
Pappano, A. J.,
and
R. A. Rembish.
Nicotine-induced restoration of action potentials to cardiac tissue depolarization by potassium.
Life Sci.
9:
1381-1388,
1970.
17.
Rampe, D.,
M. L. Roy,
A. Dennis,
and
A. M. Brown.
A mechanism for the proarrhythmic effects of cisapride (propulsid): high affinity blockage of the human cardiac potassium channel HERG.
FEBS Lett.
417:
28-32,
1997[Medline].
18.
Roy, M. L.,
R. Dumaine,
and
A. M. Brown.
HERG, a primary human ventricular target of the nonsedating antihistamie terfenadine.
Circulation
94:
817-823,
1996[Abstract/Free Full Text].
19.
Russell, M. A.,
M. Jarvis,
R. Iyer,
and
C. Feyerabend.
Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers.
Br. Med. J.
280:
972-976,
1980.
20.
Sanguinetti, M. C.,
C. Jiang,
M. E. Curran,
and
M. T. Keating.
A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel.
Cell
81:
299-307,
1995[Medline].
21.
Smith, P. L.,
T. Baukrowitz,
and
G. Yellen.
The inward rectification mechanism of the HERG cardiac potassium channel.
Nature
379:
833-836,
1996[Medline].
22.
Snyders, D. J.,
and
A. Chaudhary.
High affinity open channel block by deofetilide of HERG expressed in a human cell line.
Mol. Pharmacol.
49:
949-955,
1996[Abstract].
23.
Spector, P. S.,
M. E. Curran,
A. Zou,
M. T. Keating,
and
M. C. Sanguinetti.
Fast inactivation causes rectification of the IKr channel.
J. Gen. Physiol.
107:
611-619,
1996[Abstract/Free Full Text].
24.
Stewart, P. M.,
and
J. R. Catterall.
Chronic nicotine ingestion and atrial fibrillation.
Br. Heart J.
54:
222-223,
1985[Abstract/Free Full Text].
25.
Suessbrich, H.,
R. Schönherr,
S. H. Heinemann,
B. Attali,
F. Lang,
and
A. E. Busch.
The inhibitory effect of the antipsychotic drug haloperidol on HERG potassium channels expressed in Xenopus oocytes.
Br. J. Pharmacol.
120:
968-974,
1997[Medline].
26.
Wang, H.,
H. Shi,
X. Deng,
L. Yang,
and
Z. Wang.
Nicotine depresses the functions of multiple potassium channels (Abstract).
Biophys. J.
76:
A88,
1999.
27.
Wang, S.,
S. Liu,
M. J. Morales,
H. C. Strauss,
and
R. L. Rasmusson.
A quantitative analysis of the activation and inactivation kinetics of HERG expressed in Xenopus oocytes.
J. Physiol. (Lond.)
502:
45-60,
1998[Abstract/Free Full Text].
28.
Wang, S.,
M. J. Morales,
S. Liu,
H. C. Strauss,
and
R. L. Rasmusson.
Time-, voltage- and ionic-concentration dependence of rectification of h-erg expressed in Xenopus oocytes.
FEBS Lett.
389:
167-173,
1996[Medline].
29.
Wang, Z.
Ionic mechanisms and molecular basis of human cardiac repolarization: Implication for drug development.
Curr. Top. Pharmacol. Res. Trends
4:
19-35,
1998.
30.
Wang, Z.,
J. Kiehn,
Q. Yang,
A. Brown,
and
B. Wible.
Comparison of K+ channel binding and block produced by alternatively spliced Kv
3 subunits.
J. Biol. Chem.
271:
28311-28317,
1997[Abstract/Free Full Text].
31.
West, J. W.,
S. V. Guzman,
and
S. Bellet.
Cardiac effects of intracoronary arterial injection of nicotine.
Circ. Res.
6:
389-395,
1958[Abstract/Free Full Text].
32.
Wilde, A. A. M.,
and
G. Aksnes.
Myocardial potassium loss and cell depolarization in ischemia and hypoxia.
Cardiovasc. Res.
29:
1-15,
1995[Medline].
Am J Physiol Heart Circ Physiol 277(3):H1081-H1088
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society